시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 유전자 편집 시장 - 규모, 점유율, 성장 분석 : 기술별, 제공별, 용도별, 최종 사용자별, 지역별 산업 예측(2024-2031년)
Gene Editing Market Size, Share, Growth Analysis, By Type, By Application, By Region - Industry Forecast 2024-2031
상품코드 : 1619035
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,828,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 9,158,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,487,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 유전자 편집 시장 규모는 2022년 54억 달러로 평가되었고, 2023년 62억 4,000만 달러에서 2031년에는 197억 5,000만 달러로 성장해 예측 기간 중(2024-2031년)의 CAGR은 15.5%로 성장할 전망입니다.

세계의 유전자 편집 시장은 특히 CRISPR-Cas9와 TALEN과 같은 기술을 통한 생명 공학의 진보로 현저한 성장을 이루고 있습니다. 유전자 질환이나 암의 치료 용도의 확대와 함께, 이 시장의 주요 촉진요인이 되고 있습니다. 농업 분야에서도, 작물의 수량이나 질병에 대한 내성을 높이기 위해서 유전자 편집이 채용되고 있습니다. 제약 회사와 바이오테크놀러지 기업를 포함한 대기업은 격렬한 경쟁 속에서 연구 능력을 확대하기 위해 전략적 제휴를 실시했습니다. 아시아태평양은 헬스케어 지출 증가와 정부 지원에 힘입어 크게 성장하려 하고 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

유전자 편집 시장 규모 : 기술별, CAGR(2024-2031년)

유전자 편집 시장 규모 : 제공별, CAGR(2024-2031년)

유전자 편집 시장 규모 : 용도별, CAGR(2024-2031년)

유전자 편집 시장 규모 : 최종 사용자별, CAGR(2024-2031년)

유전자 편집 시장 규모, CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Global Gene Editing Market size was valued at USD 5.40 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 19.75 billion by 2031, growing at a CAGR of 15.5% during the forecast period (2024-2031).

The Global Gene Editing Market has seen remarkable growth due to advancements in biotechnology, particularly through technologies like CRISPR-Cas9 and TALENs. The demand for personalized medicine and increased investments in R&D are key drivers of this market, alongside the expanding therapeutic applications for genetic disorders and cancers. The agriculture sector is also embracing gene editing to enhance crop yield and resistance to diseases. Major players, including pharmaceutical and biotechnology companies, are engaged in strategic collaborations to broaden their research capabilities amid intense competition. North America leads the market, backed by advanced healthcare systems, while Asia-Pacific is poised for significant growth fueled by rising healthcare spending and governmental support. Despite ethical and regulatory challenges, the market is expected to grow substantially in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Editing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Editing Market Segmental Analysis

Global Gene Editing Market is segmented by technology, offerings, application, end user and region. Based on technology, the market is segmented into CRISPR, TALENs, zinc finger nucleases (ZFNs), restriction enzymes and others. Based on offerings, the market is segmented into products and services. Based on application, the market is segmented into genetic engineering, clinical applications, drug discovery and development and agriculture. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Editing Market

A major factor propelling the global gene editing market is the rising demand for personalized medicine. Gene editing technologies provide opportunities to craft bespoke therapies and treatments, specifically designed around an individual's unique genetic profile. This customized approach not only promises better treatment effectiveness and fewer side effects but also aims to enhance overall patient health. As awareness of personalized medicine grows, so too does the push for targeted therapies, significantly driving the adoption and progression of gene editing innovations. Consequently, the drive for personalized healthcare solutions is a crucial catalyst in the evolution of the gene editing landscape.

Restraints in the Global Gene Editing Market

A significant restraint in the global gene editing market stems from ethical and regulatory challenges inherent to the technology. The manipulation of genetic material raises intricate ethical dilemmas, especially concerning germline editing and changes that can be passed to future generations. Ongoing debates surrounding the moral implications and potential long-term effects of gene editing further complicate its acceptance. Moreover, the regulatory landscapes governing gene editing practices differ widely across jurisdictions and are in a constant state of flux. The imperative for robust ethical guidelines and unambiguous regulatory frameworks presents a notable obstacle to the market's expansion and broader implementation.

Market Trends of the Global Gene Editing Market

The global gene editing market is increasingly centered on therapeutic applications, significantly driving growth in gene therapies. As advancements in technologies such as CRISPR and TALEN enable precise interventions at the genetic level, there is a heightened focus on addressing genetic disorders, cancers, and other complex diseases through targeted treatments. This shift is catalyzed by a surge in research initiatives and collaborations among biopharmaceutical companies, academic institutions, and healthcare organizations, aimed at unlocking the full potential of gene editing for innovative therapies. The burgeoning interest in personalized medicine underscores the transformative impact of gene editing on the future of healthcare, particularly in meeting unmet medical needs.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Gene Editing Market Size by Technology & CAGR (2024-2031)

Global Gene Editing Market Size by Offerings & CAGR (2024-2031)

Global Gene Editing Market Size by Application & CAGR (2024-2031)

Global Gene Editing Market Size by End User & CAGR (2024-2031)

Global Gene Editing Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기